SHEN Li-qin2 1Department of Nuclear Medicine,the First People's Hospital of Changzhou,Changzhou 213003,China,2Department of Medicine Oncology,the 2nd Affiliated Hospital of Soochow University,Suzhou 215004,China.,.Prognostic factors in patients with stage Ⅳ non-small cell lung cancer.[J];Journal ...
Small-celllung cancer(SCLC) is a disease in which cells in your lung begin growing out of control. It starts in nerve cells or cells that make hormones. About 10% to 15% of lung cancer cases are small-cell. The other kind is called non-small-cell lung cancer. They’re different in ...
Staging cancer provides important information about the outlook of the patient's condition and helps the doctor plan the best treatment. Although doctors stage other cancers from stage I to stage IV, small-cell lung cancer is classified into two stages. Limited stage: In this stage, the tumor ...
Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in the early stages of the disease [1]. However, surgical resection is not actively recommended for patients with stage IV NSCLC presently, despite the fact that systemic therapy has been regarded as the ...
广泛期小细胞肺癌(SCLC)患者单独使用联合化疗。北美SCLC的标准治疗是给予卡铂或顺铂+依托泊苷。美国胸科医师学会(ACCP)、美国国家综合癌症网络(NCCN)和欧洲肿瘤医学学会(ESMO)的指南建议,广泛期病变的患者接受4-6个周期(但不>6个周期)的基于顺铂或卡铂的联合化疗(如顺铂+依托泊苷或依立替康)。[25,29,15] ...
Navigating treatment combinations in small-cell lung cancer The ETER701 trial demonstrates that a four-drug regimen, involving the addition of anti-angiogenesis therapy to immuno-chemotherapy, improves survival outcomes for extensive-stage small-cell lung cancer — but is more indeed better when it co...
However, the magnitude of benefit with this immune-chemotherapy strategy in SCLC is more modest than that observed in metastatic non-small-cell lung cancer patients. The immunosuppressive phenotype of SCLC plays an important role in hampering ICI efficacy and may explain the differences in outcomes ...
GUIDELINE QUESTION: In patients with metastatic, stage IV non-small-cell lung cancer (NSCLC) does chemotherapy improve survival and quality of life? OBJECTIVE: To make recommendations about the role of chemotherapy in the treatment of metastatic (stage IV) NSCLC. OUTCOMES: Survival and quality of...
Surgery plays little, if any, role in the treatment of small-cell lung cancer because almost all cancers have spread by the time they are discovered. The exceptions are the relatively small number of people (less than 15%) who get diagnosed at a very early stage of the disease, when the...
Small-cell lung cancer (SCLC) is a deadly cancer associated with smoke exposure that has neuroendocrine (NE) cell properties and is pathologically, molecularly, biologically and clinically very different from other lung cancers. While most patients with SCLC respond initially to cytotoxic therapy, almo...